Letters to the EditorGuillain–Barre Syndrome After the Third BNT162b2 Dose in an Adolescent Without Side Effects After the First and Second JabFinsterer, Josef MD, PhD Author Information Neurology & Neurophysiology Center, Vienna, Austria The author reports no conflicts of interest. Informed consent was obtained. Journal of Clinical Neuromuscular Disease 24(3):p 162-163, March 2023. | DOI: 10.1097/CND.0000000000000434 Buy Metrics Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
